Varma Mutual Pension Insurance Co Invests $17.72 Million in McKesson Corporation $MCK

Posted by George Bondi on Aug 23rd, 2026

Varma Mutual Pension Insurance Co bought a new stake in shares of McKesson Corporation (NYSE:MCK – Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 23,453 shares of the company’s stock, valued at approximately $17,721,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. University of Texas Texas AM Investment Management Co. purchased a new position in McKesson during the fourth quarter worth approximately $25,000. Swiss RE Ltd. acquired a new stake in McKesson in the fourth quarter valued at approximately $26,000. State of Wyoming purchased a new stake in shares of McKesson in the second quarter valued at approximately $29,000. Kingdom Financial Group LLC. purchased a new stake in shares of McKesson in the fourth quarter valued at approximately $33,000. Finally, Birchwood Financial Partners Inc. acquired a new position in shares of McKesson during the 4th quarter worth approximately $33,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Insider Buying and Selling

In related news, CEO Brian S. Tyler sold 8,463 shares of the firm’s stock in a transaction dated Tuesday, July 7th. The stock was sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the completion of the sale, the chief executive officer directly owned 5,919 shares of the company’s stock, valued at approximately $4,697,081.64. This trade represents a 58.84% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bradley E. Lerman sold 301 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $892.33, for a total value of $268,591.33. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 29,049 shares of company stock valued at $22,530,626. 0.06% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on MCK. Evercore reiterated an “outperform” rating on shares of McKesson in a research report on Thursday, August 6th. Robert W. Baird set a $1,015.00 price target on shares of McKesson in a report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $875.00 price objective on shares of McKesson in a research report on Friday, May 8th. William Blair assumed coverage on shares of McKesson in a report on Tuesday, April 28th. They set an “outperform” rating on the stock. Finally, UBS Group lifted their target price on shares of McKesson from $1,050.00 to $1,080.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $973.44.

Read Our Latest Stock Analysis on MCK

McKesson Price Performance

McKesson stock opened at $862.27 on Friday. The firm has a 50 day simple moving average of $820.97 and a 200-day simple moving average of $843.86. The stock has a market cap of $100.53 billion, a price-to-earnings ratio of 23.07, a price-to-earnings-growth ratio of 1.69 and a beta of 0.30. McKesson Corporation has a 1-year low of $673.38 and a 1-year high of $999.00.

McKesson (NYSE:MCK – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, beating the consensus estimate of $9.56 by $0.37. McKesson had a net margin of 1.12% and a negative return on equity of 253.21%. The firm had revenue of $105.38 billion for the quarter, compared to analyst estimates of $103.88 billion. During the same quarter in the previous year, the company earned $8.26 EPS. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. Equities analysts expect that McKesson Corporation will post 44.65 earnings per share for the current fiscal year.

McKesson Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be given a $0.94 dividend. This is an increase from McKesson’s previous quarterly dividend of $0.82. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Tuesday, September 1st. McKesson’s dividend payout ratio (DPR) is presently 8.78%.

McKesson Company Profile

(Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.